Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone Effects on Cognition and Pain in OUD
NCT04027166Phase 1Completed
- Sponsor
- Yale University
- Start
- Jul 2019
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of methadone in opioid use disorder (OUD) (2 arms), sponsored by Yale University. Primary endpoint: Changes in cognitive functioning using the Go/No-Go task. Started Jul 2019; status: completed.
02
Drugs
methadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04027166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04027166.